All Articles

Revolution Medicines' zoldonrasib delivers high response rates in trials for RAS G12D pancreatic cancer, offering a beacon of hope against a lethal disease.

The new 312-unit Allegra at Cocoa development isn't just new housing; it's a barometer for the economic boom and growing pains of Florida's Space Coast.

Neurophet's AI software, now at Raffles Medical, analyzes brain MRIs in minutes, offering a powerful new weapon in the fight against dementia and MS in Asia.

New guidelines for ankle arthritis, a condition hitting younger workers hard, expose major gaps in medical research and a market ripe for innovation.

China Yuchai's robust dividend reflects a stellar 2025, but the real story is its deep investment in electric, hybrid, and fuel cell tech for a new era.

Labrador Gold moves into the prolific White Gold District, betting a systematic, tech-driven strategy can unlock value where others left off.

A new partnership aims to build autonomous AI traders. But can these digital agents navigate the complex reality of financial markets and their regulations?

Dole's acquisition of Greenfood's produce arm isn't just expansion; it's a high-tech overhaul of the Nordic supply chain, setting a new bar for the future.

Top advisory firms ISS and Glass Lewis back Shell's takeover of ARC Resources, signaling strong shareholder support for a deal that reshapes Canada's energy map.

Eaton's latest report shows a 40% emissions cut, but the real story is its $2.1B R&D bet, positioning it against rivals in a race to power a greener world.

As the chip industry stacks its way past Moore's Law, a key battle is won in precision measurement. Nova's new deal is a critical enabler for the AI era.

As AI's energy demand threatens to overwhelm grids, CleanAmps and Excelsior are building a U.S.-owned platform to merge compute and power infrastructure.

Lifted Made's Highlandia THC beverage is a top seller in Wisconsin, but its success story is more than a local win—it's a case study in navigating a market on the brink of a federal regulatory cliff.

Agritech firm Ohalo hires a titan from Syngenta to commercialize a technology that could upend a century of potato farming and redefine global agriculture.

At Boston's Wedbush Renal Summit, Hansa Biopharma showcases its game-changing transplant drug, signaling a major strategic play for the lucrative U.S. market.

Sitemetric launches an agentic AI that not only monitors but autonomously fixes issues on job sites, signaling a major shift from passive data to active AI.

Global PR agency Diffusion expands its home portfolio, but the real story is a strategic masterclass in how challenger brands are built and new markets are won.

As Ingevity prepares its Q2 earnings, investors watch a company in flux. Divestitures and a key sale loom, testing if a leaner strategy can deliver.

Beyond convenience, a new coalition of tech firms is turning the shopping cart into a hub of data, media, and intelligence, aiming to solve retail's core paradoxes.